# Safety of AEB071 in Healthy Volunteers and to Compare the Ethnicity, Metabolic, and Safety Effects Between Caucasian and Japanese Healthy Subjects

> **NCT00416546** · PHASE1 · COMPLETED · sponsor: **Novartis** · enrollment: 96 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** AEB071

## Key facts

- **NCT ID:** NCT00416546
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10
- **Primary completion:** —
- **Final completion:** 2007-10
- **Target enrollment:** 96 (ESTIMATED)
- **Last updated:** 2008-08-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00416546

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00416546, "Safety of AEB071 in Healthy Volunteers and to Compare the Ethnicity, Metabolic, and Safety Effects Between Caucasian and Japanese Healthy Subjects". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00416546. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*